Assyro AI

Orange Book product · Generic (ANDA)

MYCOPHENOLATE MOFETIL

MYCOPHENOLATE MOFETIL

Generic (ANDA)ANDA 214871TE ABRX AMNEAL
View MYCOPHENOLATE MOFETIL familyOpen on FDA Orange Book

At a glance

Nov 02, 2021

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 02, 2021

    4 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MYCOPHENOLATE MOFETIL

Strength

200MG/ML

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

AB

Application

ANDA 214871

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MYCOPHENOLATE MOFETIL

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo